{"id":"23-ppv","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or erythema"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains purified capsular polysaccharides from 23 different pneumococcal serotypes conjugated or presented to elicit a humoral immune response. This generates protective antibodies that prevent invasive pneumococcal disease by promoting opsonization and complement-mediated killing of the bacteria. The vaccine is designed to provide broad serotype coverage for pneumococcal disease prevention.","oneSentence":"23-PPV is a pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:56:50.710Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of invasive pneumococcal disease in adults"},{"name":"Prevention of pneumococcal pneumonia and related infections"}]},"trialDetails":[{"nctId":"NCT03650114","phase":"PHASE3","title":"Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2018-12-28","conditions":"Relapsing Multiple Sclerosis","enrollment":1882},{"nctId":"NCT07058337","phase":"NA","title":"Methotrexate in Retinal Detachment With Proliferative Vitreoretinopathy","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-06-09","conditions":"Retinal Detachment","enrollment":20},{"nctId":"NCT00622843","phase":"PHASE3","title":"Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2002-12","conditions":"HIV Infections, Streptococcus Pneumoniae","enrollment":275},{"nctId":"NCT06990607","phase":"NA","title":"Compare PPV With and Without Silicone Oil in Managing Postoperative Endophthalmitis","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-01-20","conditions":"Endophthalmitis Following Cataract Surgery","enrollment":40},{"nctId":"NCT06927544","phase":"NA","title":"Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes","status":"ENROLLING_BY_INVITATION","sponsor":"The Filatov Institute of Eye Diseases and Tissue Therapy","startDate":"2025-02-01","conditions":"Idiopathic Macular Hole, Macular Hole, Macular Holes","enrollment":100},{"nctId":"NCT00404209","phase":"PHASE3","title":"Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment","status":"TERMINATED","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2007-03","conditions":"Retinal Detachment","enrollment":10},{"nctId":"NCT04192994","phase":"NA","title":"Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2019-01-01","conditions":"Endophthalmitis","enrollment":25},{"nctId":"NCT02545868","phase":"PHASE3","title":"A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2015-10-27","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":102},{"nctId":"NCT06233500","phase":"NA","title":"Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study","status":"UNKNOWN","sponsor":"Fayoum University","startDate":"2021-12-01","conditions":"Macular Holes","enrollment":28},{"nctId":"NCT04802265","phase":"","title":"EpiRetinal Membrane Peeling and Internal Limiting Membrane","status":"TERMINATED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2021-05-21","conditions":"Epiretinal Membrane, Macular Pucker, Internal Limiting Membrane","enrollment":10},{"nctId":"NCT05477693","phase":"PHASE4","title":"Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2022-10-25","conditions":"Pneumococcal Infections","enrollment":1800},{"nctId":"NCT04089033","phase":"","title":"Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN)","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2018-06-27","conditions":"Retinal Detachment, Metamorphopsia, Aniseikonia","enrollment":204},{"nctId":"NCT04989465","phase":"PHASE4","title":"A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2021-09-10","conditions":"Pneumococcal Infections","enrollment":600},{"nctId":"NCT03660345","phase":"PHASE3","title":"PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME","status":"COMPLETED","sponsor":"Rush Eye Associates","startDate":"2018-09-04","conditions":"Diabetic Retinopathy, Macular Edema","enrollment":11},{"nctId":"NCT04712786","phase":"","title":"Refractive Changes Following Vitrectomy","status":"COMPLETED","sponsor":"Bursa Retina Eye Hospital","startDate":"2020-12-01","conditions":"Retinal Detachment, Refractive Errors, Vitreous Hemorrhage","enrollment":47},{"nctId":"NCT03039491","phase":"EARLY_PHASE1","title":"Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2015-09-01","conditions":"HIV Lipodystrophy, Aging","enrollment":160},{"nctId":"NCT02477605","phase":"NA","title":"Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2015-07-16","conditions":"Vitreoretinal Disease","enrollment":137},{"nctId":"NCT02451969","phase":"PHASE3","title":"Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2015-04","conditions":"Pneumococcal Infections","enrollment":1760},{"nctId":"NCT01716507","phase":"NA","title":"23 Gauge and 20 Gauge Vitrectomy for Rhegmatogenous Retinal Detachments","status":"COMPLETED","sponsor":"Wills Eye","startDate":"2008-04","conditions":"Retinal Detachment","enrollment":46},{"nctId":"NCT01767402","phase":"PHASE1","title":"Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-10","conditions":"Pneumococcal Disease","enrollment":150},{"nctId":"NCT00148824","phase":"PHASE2","title":"Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2003-02","conditions":"HIV Infections","enrollment":212}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"23-PPV","genericName":"23-PPV","companyName":"Hoffmann-La Roche","companyId":"hoffmann-la-roche","modality":"Biologic","firstApprovalDate":"","aiSummary":"23-PPV is a pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae. Used for Prevention of invasive pneumococcal disease in adults, Prevention of pneumococcal pneumonia and related infections.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}